IL38241A - 6alpha,16alpha-dimethyl-21-hydroxy-delta1,4-pregnadiene-3,20-diones - Google Patents
6alpha,16alpha-dimethyl-21-hydroxy-delta1,4-pregnadiene-3,20-dionesInfo
- Publication number
- IL38241A IL38241A IL38241A IL3824171A IL38241A IL 38241 A IL38241 A IL 38241A IL 38241 A IL38241 A IL 38241A IL 3824171 A IL3824171 A IL 3824171A IL 38241 A IL38241 A IL 38241A
- Authority
- IL
- Israel
- Prior art keywords
- 6alpha
- 16alpha
- delta1
- pregnadiene
- diones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0095—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2059310A DE2059310C3 (de) | 1970-11-28 | 1970-11-28 | diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL38241A0 IL38241A0 (en) | 1972-01-27 |
| IL38241A true IL38241A (en) | 1975-08-31 |
Family
ID=5789778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL38241A IL38241A (en) | 1970-11-28 | 1971-11-26 | 6alpha,16alpha-dimethyl-21-hydroxy-delta1,4-pregnadiene-3,20-diones |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3828083A (es) |
| AR (1) | AR193053A1 (es) |
| AT (1) | AT312824B (es) |
| AU (1) | AU3598871A (es) |
| BE (1) | BE775901A (es) |
| CA (1) | CA933915A (es) |
| CH (2) | CH591518A5 (es) |
| CS (1) | CS166787B2 (es) |
| DE (1) | DE2059310C3 (es) |
| DK (1) | DK135131C (es) |
| EG (1) | EG10261A (es) |
| ES (1) | ES395740A1 (es) |
| FI (1) | FI49159C (es) |
| FR (1) | FR2115437B1 (es) |
| GB (1) | GB1377993A (es) |
| HU (1) | HU162900B (es) |
| IE (1) | IE35822B1 (es) |
| IL (1) | IL38241A (es) |
| NL (1) | NL7116335A (es) |
| RO (1) | RO67639A (es) |
| SE (1) | SE374109B (es) |
| SU (1) | SU474141A3 (es) |
| ZA (1) | ZA717489B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2448662C2 (de) * | 1974-10-09 | 1983-07-21 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| EP2556083A4 (en) * | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
-
1970
- 1970-11-28 DE DE2059310A patent/DE2059310C3/de not_active Expired
-
1971
- 1971-10-01 FI FI712747A patent/FI49159C/fi active
- 1971-10-05 ES ES395740A patent/ES395740A1/es not_active Expired
- 1971-10-22 CS CS7426A patent/CS166787B2/cs unknown
- 1971-11-04 HU HUSC359A patent/HU162900B/hu unknown
- 1971-11-08 ZA ZA717489A patent/ZA717489B/xx unknown
- 1971-11-18 IE IE1460/71A patent/IE35822B1/xx unknown
- 1971-11-19 RO RO7168812A patent/RO67639A/ro unknown
- 1971-11-22 GB GB5405071A patent/GB1377993A/en not_active Expired
- 1971-11-22 AU AU35988/71A patent/AU3598871A/en not_active Expired
- 1971-11-23 EG EG510/71A patent/EG10261A/xx active
- 1971-11-23 US US00201546A patent/US3828083A/en not_active Expired - Lifetime
- 1971-11-24 DK DK575371A patent/DK135131C/da not_active IP Right Cessation
- 1971-11-25 CH CH1714571A patent/CH591518A5/xx not_active IP Right Cessation
- 1971-11-25 CA CA128567A patent/CA933915A/en not_active Expired
- 1971-11-26 AR AR239286A patent/AR193053A1/es active
- 1971-11-26 SE SE7115188A patent/SE374109B/xx unknown
- 1971-11-26 IL IL38241A patent/IL38241A/xx unknown
- 1971-11-26 SU SU1948879A patent/SU474141A3/ru active
- 1971-11-26 FR FR7142463A patent/FR2115437B1/fr not_active Expired
- 1971-11-26 BE BE775901A patent/BE775901A/xx unknown
- 1971-11-26 AT AT1021071A patent/AT312824B/de not_active IP Right Cessation
- 1971-11-27 NL NL7116335A patent/NL7116335A/xx not_active Application Discontinuation
-
1975
- 1975-08-14 CH CH1062975A patent/CH617709A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH617709A5 (es) | 1980-06-13 |
| BE775901A (fr) | 1972-03-16 |
| FI49159B (es) | 1974-12-31 |
| PL74335B1 (es) | 1974-10-30 |
| CA933915A (en) | 1973-09-18 |
| ZA717489B (en) | 1972-07-26 |
| DK135131B (da) | 1977-03-07 |
| CS166787B2 (es) | 1976-03-29 |
| FI49159C (fi) | 1975-04-10 |
| DK135131C (da) | 1977-08-08 |
| IE35822B1 (en) | 1976-05-26 |
| DE2059310A1 (de) | 1972-06-08 |
| SE374109B (es) | 1975-02-24 |
| US3828083A (en) | 1974-08-06 |
| AT312824B (de) | 1974-01-25 |
| AU3598871A (en) | 1973-05-31 |
| EG10261A (en) | 1976-04-30 |
| NL7116335A (es) | 1972-05-30 |
| IL38241A0 (en) | 1972-01-27 |
| DE2059310B2 (de) | 1980-03-06 |
| CH591518A5 (es) | 1977-09-30 |
| RO67639A (ro) | 1982-10-26 |
| SU474141A3 (ru) | 1975-06-14 |
| FR2115437B1 (es) | 1975-04-18 |
| AR193053A1 (es) | 1973-03-30 |
| FR2115437A1 (es) | 1972-07-07 |
| DE2059310C3 (de) | 1980-10-30 |
| ES395740A1 (es) | 1973-12-01 |
| HU162900B (es) | 1973-04-28 |
| GB1377993A (en) | 1974-12-18 |
| SU440831A3 (es) | 1974-08-25 |
| IE35822L (en) | 1972-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA923639A (en) | Seat construction | |
| IL34974A (en) | 7alpha-methyl-3alpha,5alpha-cycloandrostanes and their 19-nor analogs | |
| AU2490571A (en) | Seating | |
| AU473594B2 (en) | Anaesthetic steroids ofthe pregnane series | |
| IL38241A (en) | 6alpha,16alpha-dimethyl-21-hydroxy-delta1,4-pregnadiene-3,20-diones | |
| IL38473A0 (en) | New 6alpha-fluoro-16alpha,18-dimethyl-delta1,4-pregnadiene-3,20-diones | |
| IL34976A0 (en) | New 21,21-dichloro steroids of the pregnane series | |
| AU468273B2 (en) | 16, 17-cyclopropa steroids ofthe androstane series | |
| IL38376A0 (en) | Novel steroids | |
| CA959046A (en) | Cardenolides and bufadienolides | |
| AU4145272A (en) | 6alpha,9alpha-difluorosteroids of the pregnane series | |
| CA945140A (en) | Steroids | |
| IL33017A (en) | 6alpha9alpha,21-trihalo-11beta-hydroxy-16alpha-methyl-pregna-1,4-diene-3,20-diones | |
| IE36471L (en) | 6-azido-21-oxygenated steroids. | |
| IL32219A0 (en) | 9beta,10alpha-steroids of the pregnane series | |
| CA856772A (en) | 6-halogeno-6-dehydro-3-keto steroids | |
| CA834718A (en) | Steroids | |
| CA850643A (en) | Steroids | |
| CA835969A (en) | Steroids | |
| AU462506B2 (en) | 17ox-PROPADIEWYL STEROIDS | |
| CA841610A (en) | Steroids | |
| IL36180A (en) | 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-21-halo-pregn-4-ene-3,20-dione and derivatives thereof | |
| AU443789B2 (en) | 9,21-DIFLUORO-11b-HYDROXY-16-METHYLENE-17-ACYLOXY-PREGNANE STEROIDS | |
| AU3661971A (en) | New halogeno pregnadiene | |
| CA859136A (en) | 16-ALKYL-11-OXYGENATED-4-PREGNENE-17.alpha.-OL-3,20-DIONE AND THE CORRESPONDING 1,4-PREGNADIENE COMPOUNDS |